Stifel maintained its Buy rating on HubSpot (NYSE:HUBS) and raised the price target on the shares to $880 from $750 following ...
HubSpot has announced its agreement to acquire Frame Al, an Al-powered conversation intelligence platform. This acquisition ...
Revance Therapeutics (RVNC) sunk 20% in premarket trading after it agreed to a revised deal with Crown Laboratories, with the takeover price cut by more than half. Revance  (NASDAQ:RVNC) will now ...